e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Kyverna Therapeutics, Inc.
Kyverna Therapeutics Announces Positive Interim Phase 2 Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis at AANEM 2025
October 29, 2025
From
Kyverna Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KYTX
Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigator-Initiated Trial Presented at ACR Convergence 2025
October 25, 2025
From
Kyverna Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KYTX
Kyverna Therapeutics to Host Conference Call on Interim Phase 2 Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis
October 22, 2025
From
Kyverna Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KYTX
Kyverna Therapeutics Highlights Potential of KYV-101 in Multiple Sclerosis with Data from Phase 1 Investigator-Initiated Trials to be Presented at ECTRIMS
September 24, 2025
From
Kyverna Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KYTX
Kyverna Therapeutics to Highlight Interim Phase 2 Data from KYV-101 KYSA-6 Study in Myasthenia Gravis at AANEM 2025
September 15, 2025
From
Kyverna Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KYTX
Kyverna Therapeutics Highlights Neuroimmunology CAR T Franchise and Registrational Phase 3 Trial Design in Myasthenia Gravis at Virtual KOL Event
August 28, 2025
From
Kyverna Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KYTX
Kyverna Therapeutics to Present at Upcoming Investor Conferences in September
August 25, 2025
From
Kyverna Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KYTX
Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
August 12, 2025
From
Kyverna Therapeutics, Inc.
Via
GlobeNewswire
Tickers
KYTX
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert